Clinical Trial Update: A Study of Apatinib in Recurrent/Metastatic Adenoid Cystic Carcinoma of the Head and Neck [Phase 2]

View source ↗

Summary

Phase 2 trial investigating apatinib for adenoid cystic carcinoma of the head and neck; current status is unknown.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Adenoid Cystic Carcinoma

Drugs mentioned

• Apatinib (apatinib)

Snippet

Sponsor: Shanghai Ninth People's Hospital Affiliated to Shanghai Jiao Tong University | Conditions: Adenoid Cystic Carcinoma | Phase 2 | Status: UNKNOWN